Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 9Gynecologic 1

Conditions

Ovarian Neoplasms 14Carcinoma, Ovarian Epithelial 11Fallopian Tube Neoplasms 10Uterine Cervical Neoplasms 9Endometrial Neoplasms 5Peritoneal Neoplasms 3Sarcoma 2Brenner Tumor 2Vomiting 1Testicular Neoplasms 1Teratoma 1Stomach Neoplasms 1Sarcoma, Synovial 1Sarcoma, Endometrial Stromal 1Sarcoma, Alveolar Soft Part 1Rhabdomyosarcoma 1Rectal Neoplasms 1Pheochromocytoma 1Paget's Disease, Mammary 1Ovarian Germ Cell Cancer 1Neutropenia 1Neurofibrosarcoma 1Nausea 1Malignant mesenchymal tumor 1Liposarcoma 1Leiomyosarcoma 1Kidney Neoplasms 1Histiocytoma, Malignant Fibrous 1High-risk Endometrial Cancer 1Hemangiosarcoma 1

Interventions

Tamoxifen 1Medroxyprogesterone 1Immunohistochemistry 1Fluorescent Antibody Technique 1Flow Cytometry 1Fentanyl 1Chemotherapy, Adjuvant 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Carcinoma In Situ × Chemotherapy, Adjuvant × Gynecologic × Clear all
NCT00002920 2012-10-31

S9630, Medroxyprogesterone in Treating Women With Breast Cancer

SWOG Cancer Research Network

Phase 3 Completed
313 enrolled
BreastGynecologic

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Paget's Disease, Mammary, Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡